PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DUOL vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DUOL and NVO is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

DUOL vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Duolingo, Inc. (DUOL) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%AugustSeptemberOctoberNovemberDecember2025
108.52%
-33.83%
DUOL
NVO

Key characteristics

Sharpe Ratio

DUOL:

1.54

NVO:

-0.49

Sortino Ratio

DUOL:

2.21

NVO:

-0.47

Omega Ratio

DUOL:

1.29

NVO:

0.93

Calmar Ratio

DUOL:

2.29

NVO:

-0.40

Martin Ratio

DUOL:

5.51

NVO:

-1.01

Ulcer Index

DUOL:

15.00%

NVO:

18.35%

Daily Std Dev

DUOL:

53.88%

NVO:

37.45%

Max Drawdown

DUOL:

-68.92%

NVO:

-71.31%

Current Drawdown

DUOL:

-5.98%

NVO:

-41.80%

Fundamentals

Market Cap

DUOL:

$14.38B

NVO:

$357.98B

EPS

DUOL:

$1.84

NVO:

$2.96

PE Ratio

DUOL:

177.62

NVO:

29.56

Total Revenue (TTM)

DUOL:

$538.47M

NVO:

$204.72B

Gross Profit (TTM)

DUOL:

$391.23M

NVO:

$173.22B

EBITDA (TTM)

DUOL:

$53.37M

NVO:

$108.42B

Returns By Period

In the year-to-date period, DUOL achieves a 8.17% return, which is significantly higher than NVO's -0.96% return.


DUOL

YTD

8.17%

1M

5.21%

6M

108.53%

1Y

81.94%

5Y*

N/A

10Y*

N/A

NVO

YTD

-0.96%

1M

-2.50%

6M

-33.83%

1Y

-21.00%

5Y*

24.95%

10Y*

16.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DUOL vs. NVO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DUOL
The Risk-Adjusted Performance Rank of DUOL is 8686
Overall Rank
The Sharpe Ratio Rank of DUOL is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of DUOL is 8484
Sortino Ratio Rank
The Omega Ratio Rank of DUOL is 8383
Omega Ratio Rank
The Calmar Ratio Rank of DUOL is 9292
Calmar Ratio Rank
The Martin Ratio Rank of DUOL is 8383
Martin Ratio Rank

NVO
The Risk-Adjusted Performance Rank of NVO is 2121
Overall Rank
The Sharpe Ratio Rank of NVO is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 2020
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 2020
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 2222
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 2222
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DUOL vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Duolingo, Inc. (DUOL) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DUOL, currently valued at 1.54, compared to the broader market-2.000.002.001.54-0.49
The chart of Sortino ratio for DUOL, currently valued at 2.21, compared to the broader market-4.00-2.000.002.004.002.21-0.47
The chart of Omega ratio for DUOL, currently valued at 1.29, compared to the broader market0.501.001.502.001.290.93
The chart of Calmar ratio for DUOL, currently valued at 2.29, compared to the broader market0.002.004.006.002.29-0.40
The chart of Martin ratio for DUOL, currently valued at 5.51, compared to the broader market-20.00-10.000.0010.0020.005.51-1.01
DUOL
NVO

The current DUOL Sharpe Ratio is 1.54, which is higher than the NVO Sharpe Ratio of -0.49. The chart below compares the historical Sharpe Ratios of DUOL and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
1.54
-0.49
DUOL
NVO

Dividends

DUOL vs. NVO - Dividend Comparison

DUOL has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.69%.


TTM20242023202220212020201920182017201620152014
DUOL
Duolingo, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
1.69%1.68%1.00%1.20%1.34%1.86%2.14%2.47%2.12%3.93%1.31%1.96%

Drawdowns

DUOL vs. NVO - Drawdown Comparison

The maximum DUOL drawdown since its inception was -68.92%, roughly equal to the maximum NVO drawdown of -71.31%. Use the drawdown chart below to compare losses from any high point for DUOL and NVO. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-5.98%
-41.80%
DUOL
NVO

Volatility

DUOL vs. NVO - Volatility Comparison

Duolingo, Inc. (DUOL) has a higher volatility of 14.09% compared to Novo Nordisk A/S (NVO) at 13.18%. This indicates that DUOL's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
14.09%
13.18%
DUOL
NVO

Financials

DUOL vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Duolingo, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab